Nosocomial infections with antibiotic-resistant bacteria increase the cost of health care, length of hospital stay and mortality. The incidence of antibiotic-resistant bacteria such as imipenem-resistant Pseudomonas aeruginosa is increasing. Present-day infection control measures have failed to curb the increasing incidence of antibiotic-resistant bacteria. Few new antibiotics that target resistant gram-negative bacteria are under development. All these reasons underscore the need to better understand the causal risk factors of prototypical antibiotic-resistant bacteria such as imipenem-resistant Pseudomonas that will lead to cost-effective prospective interventions. No previous study of the magnitude proposed in this grant (5-year cohort) or with the clinical and molecular epidemiologic rigor proposed below has been done to assess the causality and interaction of the following risk factors for imipenem-resistant Pseudomonas: antibiotic exposure, patient-to-patient transmission,and being colonized with a previously susceptible identical species strain.
Specific aims are:
Aim 1 : Determine the association between prior treatment with imipenem and other anti-pseudomonal antibiotics and the outcome of acquisition of imipenem-resistant Pseudomonas.
Aim 2 : Use molecular techniques (MLST and PFGE) to quantify the percent of acquisition of imipenem-resistant P. aeruginosa that is due to patient-to-patient transmission. ? Aim 3: In the subset of patients who are initially colonized with imipenem-susceptible Pseudomonas aeruginosa and subsequently found to carry an imipenem-resistant strain, we will use MLST and PFGE to assess the genetic relatedness in a given patient between the imipenem-susceptible Pseudomonas and imipenem-resistant Pseudomonas aeruginosa isolate and determine the mechanism of resistance. ? Aim 4: Determine the cost-effectiveness of three different infection control interventions. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI060859-01A1
Application #
6928055
Study Section
Special Emphasis Panel (ZRG1-HOP-N (90))
Program Officer
Korpela, Jukka K
Project Start
2005-03-01
Project End
2009-02-28
Budget Start
2005-03-01
Budget End
2006-02-28
Support Year
1
Fiscal Year
2005
Total Cost
$371,250
Indirect Cost
Name
University of Maryland Baltimore
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Johnson, J Kristie; Robinson, Gwen L; Zhao, LiCheng et al. (2016) Comparison of molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients. Diagn Microbiol Infect Dis 86:345-350
Johnson, J Kristie; Wilson, Lucy E; Zhao, Licheng et al. (2014) Point prevalence of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in Maryland. Infect Control Hosp Epidemiol 35:443-5
Hazen, Tracy H; Zhao, LiCheng; Boutin, Mallory A et al. (2014) Comparative genomics of an IncA/C multidrug resistance plasmid from Escherichia coli and Klebsiella isolates from intensive care unit patients and the utility of whole-genome sequencing in health care settings. Antimicrob Agents Chemother 58:4814-25
Hazen, Tracy H; Zhao, LiCheng; Sahl, Jason W et al. (2014) Characterization of Klebsiella sp. strain 10982, a colonizer of humans that contains novel antibiotic resistance alleles and exhibits genetic similarities to plant and clinical Klebsiella isolates. Antimicrob Agents Chemother 58:1879-88
Ajao, Adebola O; Johnson, J Kristie; Harris, Anthony D et al. (2013) Risk of acquiring extended-spectrum ?-lactamase-producing Klebsiella species and Escherichia coli from prior room occupants in the intensive care unit. Infect Control Hosp Epidemiol 34:453-8
Strassle, Paula; Thom, Kerri A; Johnson, J Kristie et al. (2012) The effect of terminal cleaning on environmental contamination rates of multidrug-resistant Acinetobacter baumannii. Am J Infect Control 40:1005-7
Thom, Kerri A; Maragakis, Lisa L; Richards, Katie et al. (2012) Assessing the burden of Acinetobacter baumannii in Maryland: a statewide cross-sectional period prevalence survey. Infect Control Hosp Epidemiol 33:883-8
Ranke, Tarah D; Strassle, Paula; Harris, Anthony D et al. (2012) Recovery of Gram-negative bacilli in stored endotracheal aspirates. J Clin Microbiol 50:2791-2
Thom, Kerri A; Howard, Tracy; Sembajwe, Sophie et al. (2012) Comparison of swab and sponge methodologies for identification of Acinetobacter baumannii from the hospital environment. J Clin Microbiol 50:2140-1
Hazen, Tracy H; Robinson, Gwen L; Harris, Anthony D et al. (2012) Genome sequence of Klebsiella oxytoca 11492-1, a nosocomial isolate possessing a FOX-5 AmpC ýý-lactamase. J Bacteriol 194:3028-9

Showing the most recent 10 out of 40 publications